Back

Heart failure and tachycardiomyopathy in a patient taking ibrutinib: a novel tyrosine kinase inhibitor.

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Clinical Cases Cardiotoxicity of Drugs and Other Therapies HFA Premium Access Heart Failure 2019

About the speaker

Photo
Mrs Mireia Codina

Hospital de Basurto, Bilbao (Spain)

34 More presentations in this session

Presentation thumbnail
Miss A. Burducea (Bucuresti, RO)
Abstract
Presentation thumbnail
Doctor A. Siama (Maroussi-Athens, GR)
Abstract Slides
Presentation thumbnail
Doctor A. Kalogeris (Athens, GR)
Abstract
Presentation thumbnail
Doctor J. Zakrzewska-Koperska (Warsaw, PL)
Abstract
Presentation thumbnail

Access the full session

Session thumbnail
Poster Session 2 - Clinical Cases

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Session
Chronic kidney disease and heart failure
thumbnail
Congress Session
Rare causes of heart failure
thumbnail
Congress Session
Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments